Cancer: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
**[[Molecular_Playground/Caspase-7_Dynamics|Caspase-7 Dynamics]] | **[[Molecular_Playground/Caspase-7_Dynamics|Caspase-7 Dynamics]] | ||
**[[Molecular_Playground/Caspase-9_Regulation|Caspase-9 Regulation]] | **[[Molecular_Playground/Caspase-9_Regulation|Caspase-9 Regulation]] | ||
*[[User:Greg_Black/Sandbox_1|Cisplatin Information]] | |||
*[[Michael Purol Sandbox 1|Cyclin Dependent Kinase Inhibitor]] | |||
*[[6-deoxyerythronolide_B_synthase_%28DEBS%29|DEBS]] | *[[6-deoxyerythronolide_B_synthase_%28DEBS%29|DEBS]] | ||
*[[Farnesoid X Receptor]] | *[[Farnesoid X Receptor]] | ||
| Line 36: | Line 38: | ||
**[[Phosphatidylinositol 3-Kinase]] | **[[Phosphatidylinositol 3-Kinase]] | ||
**[[SRC]] | **[[SRC]] | ||
*[[Matt Routh sandbox|MDM2 Bound to p53]] | *[[Matt Routh sandbox|MDM2 Bound to p53]] | ||
*[[P-glycoprotein:_Why_Cancer_Drugs_Fail|P-Glycoprotein: Why Cancer Drugs Fail]] | *[[P-glycoprotein:_Why_Cancer_Drugs_Fail|P-Glycoprotein: Why Cancer Drugs Fail]] | ||
